Caitong International Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Sell
10,214
-87,552
-90% -$4.75M 0.06% 257
2026
Q1
$6.13M Buy
97,766
+93,752
+2,336% +$7.5M 1.13% 16
2025
Q4
$383K Sell
4,014
-123
-3% -$12.1K 0.09% 114
2025
Q3
$404K Buy
+4,137
New +$428K 0.28% 38
2025
Q2
Sell
-657
Closed -$66.3K 2031
2025
Q1
$66.3K Sell
657
-338
-34% -$34K 0.05% 401
2024
Q4
$88.9K Buy
+995
New +$87.6K 0.09% 274

Other funds holding BSX

Caitong International Asset Management's BSX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Boston Scientific (BSX) stake by 90% in Q2 2026, selling an estimated $4.75M and leaving 10,214 shares worth $436K. The position accounts for 0.06% of the portfolio, ranked #257.

Caitong International Asset Management first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.13M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Caitong International Asset Management held 10,214 shares of Boston Scientific worth $436K as of Q2 2026.
  • Caitong International Asset Management sold 87,552 Boston Scientific shares in Q2 2026, an estimated $4.75M.
  • Boston Scientific made up 0.06% of Caitong International Asset Management's portfolio in Q2 2026, its #257 holding.
  • Caitong International Asset Management first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Caitong International Asset Management's Boston Scientific position peaked at $6.13M in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.